| Name | Title | Contact Details |
|---|
QA Edge is a Wilmington, DE-based company in the Software and Internet sector.
Appthority`s App Risk Management service automates discovering the hidden behaviors of millions of apps and allowing the apps that employees can securely use. Only Appthority combines the largest global database of millions of analyzed public and enterprise apps with a policy management engine to speed app review and approval and enforce custom, acceptable use polices for thousands of employees within minutes. With unprecedented visibility and control over risky app behaviors, Appthority enables companies to leverage mobility and empower a smarter, safer, mobile workforce. Headquartered in San Francisco, Appthority is venture-backed by U.S. Venture Partners (USVP) and Venrock.
MediaNet Group Technologies is a publicly held Company (OTCBB:MEDG) that encompasses an integrated group of operating divisions that revolve around the many aspects of technology and media including, branded rewards programs web portal programs, television and video production and intellectual properties.
We are .CLUB – the ideal domain extension for the social world we live in. The Internet has connected us in ways we never dreamed of. Everyday, communities and groups are forming around every imaginable interest. Whether a tribe of 2 or 2000, there`s never been a better, easier time for people to come together around a common passion. A better time to be a part of a club. Now you can get the perfect yourname.club – a URL that has meaning and marketing value… that immediately tells the world you are about people sharing a common interest, whatever that passion may be.
Since the Company's inception in 1999, scientists and engineers at AutoGenomics have endeavored to create automated technologies that simplify the complex test processes inherent in genetic analysis within a format that is user friendly and increases productivity in the clinical laboratory. The INFINITI® system is designed specifically for processing AutoGenomics' unique proprietary BioFilmChip® microarrays that can be multiplexed and configured with hundreds of biomarkers to assess disease signatures from a single sample specimen. The INFINITI system provides clinical laboratories with significant improvements in laboratory productivity, workflow and cost per reportable result. Corporate Overview